Welcome to our dedicated page for Red Violet SEC filings (Ticker: RDVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Red Violet, Inc.'s SEC filings document the reporting record of an analytics and information solutions company focused on identity intelligence. Form 8-K filings furnish quarterly and annual earnings releases, conference call transcripts and related exhibits covering operating results and financial condition. Other 8-K disclosures address Regulation FD materials, management agreements and capital allocation actions such as the company's stock repurchase program.
Red Violet proxy filings cover public-company governance, executive compensation, equity awards and related compensation disclosures. Together, the filings describe the company's formal reporting around its CORE™ identity intelligence business, governance framework, executive arrangements, capital structure activity and material corporate events.
Red Violet, Inc. reported that on January 9, 2026 it entered into amendments to the employment agreements of its four senior leaders: Chief Executive Officer Derek Dubner, President James Reilly, Chief Financial Officer Daniel MacLachlan, and Chief Information Officer Jeffrey Dell. These amendments extend the expiration date of each executive’s employment term by approximately three years, from March 26, 2027 to March 31, 2030. The company notes that the brief description is qualified in its entirety by the full amendment texts, which are filed as exhibits to the report.
Red Violet, Inc. is registering up to $150,000,000 of mixed securities under a shelf prospectus. The company may from time to time offer common stock, preferred stock, debt securities, depositary shares, warrants and units, with specific terms, prices and net proceeds detailed in future prospectus supplements. Red Violet intends to use any proceeds for general corporate purposes, including working capital, capital expenditures, potential repurchases or redemptions of securities, and possible acquisitions or business expansion.
Red Violet, a NASDAQ-listed smaller reporting company trading under the symbol RDVT, provides AI/ML-driven identity intelligence through its CORE platform and its IDI and FOREWARN brands. Its solutions support use cases such as identity verification, fraud prevention and regulatory compliance, delivered mainly via subscription and usage-based licensing.
Red Violet, Inc. has filed a shelf registration statement on Form S-3 to offer from time to time up to $150,000,000 of mixed securities, including common stock, preferred stock, debt securities, depositary shares, warrants and units. These securities may be sold in one or more future offerings, with final terms described in separate prospectus supplements.
The company plans to use any net proceeds for general corporate purposes such as working capital, capital expenditures, potential share repurchases or redemptions, and possible acquisitions or business expansion. Red Violet provides AI- and machine-learning driven identity intelligence solutions primarily through its IDI and FOREWARN brands. As of November 17, 2025, it had 14,088,231 shares of common stock outstanding, and its common stock trades on NASDAQ under the symbol RDVT, with a last reported sale price of $54.33 per share.
Red Violet, Inc. (RDVT) reported insider activity: Chief Information Officer Jeffrey Dell sold a total of 10,000 shares of common stock across multiple trades from 11/10/2025 to 11/13/2025. The sales were executed in multiple transactions with weighted average prices ranging from $56.72 to $58.81, as detailed in footnotes.
Following these transactions, Dell beneficially owns 155,934 shares directly. This figure includes 20,000 RSUs granted on 11/30/2023 that vest in two equal installments on 12/1/2025 and 12/1/2026, and 15,750 RSUs granted on 11/4/2024 that vest in two equal installments on 11/1/2026 and 11/1/2027. The filing notes that each day’s sales were comprised of multiple trades within disclosed price ranges.
Red Violet (RDVT) reported insider activity by CEO and Chairman Derek Dubner. Between 11/10/2025 and 11/13/2025, he sold a total of 15,000 shares of common stock in seven open‑market transactions. Weighted average prices per tranche ranged from $56.73 to $58.81, with disclosed trade price ranges spanning $56.40 to $58.92.
Following these sales, his beneficial ownership was 556,000 shares, held directly. This figure includes 26,666 RSUs granted on November 30, 2023, scheduled to vest in equal parts on December 1, 2025 and December 1, 2026, and 21,000 RSUs granted on November 4, 2024, scheduled to vest in equal parts on November 1, 2026 and November 1, 2027.
Red Violet, Inc. (RDVT) CFO Daniel MacLachlan reported open‑market sales of common stock on 11/10–11/13/2025, as disclosed in a Form 4. Each day’s trades were executed in multiple transactions, with weighted average prices per share of $58.81 (11/10), $58.03 (11/10), $57.81 (11/11), $58.10 (11/12), $57.80 (11/12), $57.57 (11/13), and $56.73 (11/13). The transactions occurred within an overall price range of $56.40 to $58.92, as noted in the footnotes.
Following these reported sales, the table shows 358,163 shares beneficially owned after an 11/13/2025 transaction. The filing also notes 26,666 RSUs granted on 11/30/2023 vesting in two equal installments on December 1, 2025 and December 1, 2026, and 21,000 RSUs granted on 11/4/2024 vesting in two equal installments on November 1, 2026 and November 1, 2027, each convertible into common stock on a one‑for‑one basis.
Red Violet (RDVT) President James Reilly reported multiple open‑market sales of common stock. Tranches executed from November 10–13, 2025 included 733 shares at a weighted average price of $58.81; 6,273 at $58.03; 2,184 at $57.81; 651 at $58.10; 3,448 at $57.80; 445 at $57.57; and 1,266 at $56.73. Following these transactions, he beneficially owned 231,078 shares directly.
The reported holdings include 26,666 RSUs granted November 30, 2023 (vesting December 1, 2025 and December 1, 2026) and 21,000 RSUs granted November 4, 2024 (vesting November 1, 2026 and November 1, 2027).
Red Violet, Inc. furnished, under Regulation FD, a press release and a conference call transcript announcing financial results for the third quarter ended September 30, 2025. The company issued the materials on November 5, 2025 and provided the transcript as Exhibit 99.1.
The furnished information, including Exhibit 99.1, is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically stated. An Inline XBRL cover page (Exhibit 104) accompanies the filing.
Red Violet, Inc. (RDVT) reported strong Q3 performance. Revenue rose to $23.1 million, up 21% year over year, while net income increased to $4.2 million, up 145%. Diluted EPS was $0.29. Adjusted EBITDA reached $9.0 million with a 39% margin, reflecting operating leverage as gross margin improved to 73%.
Cash and cash equivalents were $45.4 million as of September 30, 2025. Operating cash flow for the quarter was $10.2 million, and for the nine months it was $22.7 million. The company paid a special cash dividend of $0.30 per share in February and repurchased 15,437 shares in Q3. The board expanded the stock repurchase authorization to $30.0 million, with $18.9 million remaining.
Customer metrics expanded: IDI billable customers reached 9,853 and FOREWARN users 372,209. The company disclosed total commitments of $44.9 million under data licensing and cloud agreements and noted an ongoing Daniel’s Law legal action in New Jersey; the insurer has been notified and coverage is anticipated, subject to limits.